Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.

Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.

Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.

Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).

Jordan, a melanoma survivor, shares her experience with melanoma, BRAF mutation testing and the importance of patient empowerment.

Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.

Our Global Head of Talent Acquisition & Staffing talks about ongoing recruitment efforts to create a more diverse and inclusive organization.

In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.

Novartis works tirelessly with third-party organizations to improve access to cancer care.

Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.